ADVFN ADVFN

Hot Features

Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Organon and Co

Organon and Co (OGN)

13,36
-0,04
(-0,30%)
Fermé 06 Juin 10:00PM
13,36
0,00
(0,00%)
Après les heures de négociation: 1:00AM

Organon and Co (OGN) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
13,36
( -0,30% )
Prix Achat
-
Prix Vente
-
Volume échangé
2 188 332
13,37 Fourchette du Jour 13,40
5,69 Plage de 52 semaines 13,48
Cap du marché
Clôture Veille
13,40
Ouverture
13,38
Dernière Transaction
10
@
13.35
Dernière heure de transaction
Volume financier
US$ 29 309 685
VWAP
13,3936
Volume moyen (3 m)
US$ 8 762 978
Actions en circulation
262 600 862
Rendement du Dividende (LTM)
0,08 (0,60%)
Ratio Cours sur Bénéfices
14,16
Bénéfice par action (BPA)
0,94
Chiffre d'affairess (LTM)
6,16B
Bénéfice net (LTM)
246M

À propos de Organon and Co

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women’s health portfolio comp... Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women’s health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Jersey City, United States
Fondé
2026
Organon and Co est coté dans le secteur Healthcare de la New York Stock Exchange avec le ticker OGN. Le dernier cours de clôture d'Organon était de US$13,40. Au cours de la dernière année, les actions de Organon ont été négociées dans une fourchette de prix de US$ 5,69 à US$ 13,48.

Organon compte actuellement 262 600 862 actions en circulation. La capitalisation boursière d'Organon est de US$3,51 milliard. Organon a un ratio cours/bénéfice (ratio PE) de 14.16.

OGN Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.010.074906367041213.3513.413.34308041313.36640641CS
40013.3613.4813.28364019313.37203411CS
127.02110.725552056.3413.485.69914780611.239498CS
266.2287.11484593847.1413.485.6969951419.92934063CS
523.8240.04192872129.5413.485.6959039449.46114681CS
156-6.53-32.830568124719.8924.085.69412159212.6643996CS
260-20.67-60.740523067934.0339.4755.69333949517.16278895CS

OGN - Frequently Asked Questions (FAQ)

What is the current Organon and Co share price?
The current share price of Organon and Co is US$ 13,36
How many Organon and Co shares are in issue?
Organon and Co has 262 600 862 shares in issue
What is the market cap of Organon and Co?
The market capitalisation of Organon and Co is USD 3,51B
What is the 1 year trading range for Organon and Co share price?
Organon and Co has traded in the range of US$ 5,69 to US$ 13,48 during the past year
What is the PE ratio of Organon and Co?
The price to earnings ratio of Organon and Co is 14,16
What is the cash to sales ratio of Organon and Co?
The cash to sales ratio of Organon and Co is 0,57
What is the registered address of Organon and Co?
The registered address for Organon and Co is 30 Hudson Street, Jersey City, New Jersey, 07302
What is the Organon and Co website address?
The website address for Organon and Co is www.organon.com
Which industry sector does Organon and Co operate in?
Organon and Co operates in the Pharmaceuticals sector

OGN Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion